DE60331298D1 - Triglyceridfett - Google Patents

Triglyceridfett

Info

Publication number
DE60331298D1
DE60331298D1 DE60331298T DE60331298T DE60331298D1 DE 60331298 D1 DE60331298 D1 DE 60331298D1 DE 60331298 T DE60331298 T DE 60331298T DE 60331298 T DE60331298 T DE 60331298T DE 60331298 D1 DE60331298 D1 DE 60331298D1
Authority
DE
Germany
Prior art keywords
fat
triglycerides
acid residues
fatty acid
carbon atoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60331298T
Other languages
English (en)
Inventor
Eckhard Floeter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Unilever NV
Original Assignee
Unilever NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever NV filed Critical Unilever NV
Application granted granted Critical
Publication of DE60331298D1 publication Critical patent/DE60331298D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A23D7/001—Spread compositions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/555—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound pre-targeting systems involving an organic compound, other than a peptide, protein or antibody, for targeting specific cells
    • A61K47/557—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound pre-targeting systems involving an organic compound, other than a peptide, protein or antibody, for targeting specific cells the modifying agent being biotin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/66—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid the modifying agent being a pre-targeting system involving a peptide or protein for targeting specific cells
    • A61K47/665—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid the modifying agent being a pre-targeting system involving a peptide or protein for targeting specific cells the pre-targeting system, clearing therapy or rescue therapy involving biotin-(strept) avidin systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6891—Pre-targeting systems involving an antibody for targeting specific cells
    • A61K47/6897—Pre-targeting systems with two or three steps using antibody conjugates; Ligand-antiligand therapies
    • A61K47/6898—Pre-targeting systems with two or three steps using antibody conjugates; Ligand-antiligand therapies using avidin- or biotin-conjugated antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6901—Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11C—FATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
    • C11C3/00—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom
    • C11C3/04—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by esterification of fats or fatty oils
    • C11C3/10—Ester interchange
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/873—Techniques for producing new embryos, e.g. nuclear transfer, manipulation of totipotent cells or production of chimeric embryos
    • C12N15/877—Techniques for producing new mammalian cloned embryos
    • C12N15/8775—Murine embryos
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0006—Modification of the membrane of cells, e.g. cell decoration
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0604—Whole embryos; Culture medium therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Developmental Biology & Embryology (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Immunology (AREA)
  • Nanotechnology (AREA)
  • Biophysics (AREA)
  • Polymers & Plastics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Food Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Medical Informatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
DE60331298T 2002-04-09 2003-03-10 Triglyceridfett Expired - Lifetime DE60331298D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02076376 2002-04-09
PCT/EP2003/002625 WO2003084337A1 (en) 2002-04-09 2003-03-10 Triglyceride fat

Publications (1)

Publication Number Publication Date
DE60331298D1 true DE60331298D1 (de) 2010-04-01

Family

ID=28685931

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60331298T Expired - Lifetime DE60331298D1 (de) 2002-04-09 2003-03-10 Triglyceridfett

Country Status (12)

Country Link
US (1) US7524524B2 (de)
EP (1) EP1492410B1 (de)
AT (1) ATE457649T1 (de)
AU (1) AU2003218752B2 (de)
BR (1) BR0308747B1 (de)
CA (1) CA2481700C (de)
DE (1) DE60331298D1 (de)
MX (1) MXPA04009732A (de)
PL (1) PL205287B1 (de)
RU (1) RU2307517C2 (de)
WO (1) WO2003084337A1 (de)
ZA (1) ZA200407149B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6388113B1 (en) 1999-06-04 2002-05-14 Consejo Superior De Investigaciones Cientificas ( Csic) High oleic/high stearic sunflower oils
BRPI0313344B1 (pt) * 2002-08-12 2015-05-26 Unilever Nv Preparação de uma fase graxa, emulsão água-em-óleo comestível, seu processo de preparação, composição comestível e seus processos de preparação
AU2004262853B2 (en) 2003-07-17 2008-06-05 Upfield Europe B.V. Process for the preparation of an edible dispersion comprising oil and structuring agent
GB0409156D0 (en) * 2004-04-24 2004-05-26 Haye Pierre A procedure to manufacture a texturized, thermo-resistant and thermo-irreversible gel composed of vegetable and/or animal fats and the product made with this
BRPI0606151A8 (pt) * 2005-01-28 2017-09-19 Unilever Nv Dispersão entornável comestível e processo para a preparação de uma dispersão comestível contendo gordura
WO2006087092A2 (en) 2005-02-17 2006-08-24 Unilever N.V. Fat granules
EP1931211B1 (de) * 2005-09-26 2008-12-10 Unilever N.V. Nichthydriertes hartfett
US8431177B2 (en) * 2007-08-02 2013-04-30 Bunge Oils, Inc. Shortenings and methods of making and using thereof
ATE553655T1 (de) * 2008-01-10 2012-05-15 Team Foods Colombia Sa Festes, trans-fettsäurefreies fettprodukt mit niedrigem gehalt an gesättigten fetten
WO2009152150A1 (en) * 2008-06-11 2009-12-17 General Mills Marketing, Inc. Hydrated fat piece compositions and dough articles made therefrom
EA201100983A1 (ru) 2008-12-19 2011-12-30 Юнилевер Н.В. Съедобные жировые порошки
WO2010069750A1 (en) * 2008-12-19 2010-06-24 Unilever Nv Edible fat powders
EP2584907B1 (de) 2010-06-22 2014-04-23 Unilever NV Essbare fettpulver
CA2820360C (en) 2010-12-17 2018-10-30 Unilever Plc Edible water in oil emulsion
EP2651234B1 (de) 2010-12-17 2015-01-21 Unilever N.V. Verfahren zur kompaktierung eines mikroporösen fettpulvers und auf diese weise erhaltenes kompaktiertes fettpulver
EP2706863B1 (de) 2011-05-09 2017-10-04 General Mills, Inc. Fettzusammensetzung welche backfettteilchen enthält, sowie backfettzusammensetzungen ohne zugegebenes nicht-umgeestertes hochschmelzendes fett und deren produkte
JP5173086B2 (ja) * 2011-05-17 2013-03-27 日清オイリオグループ株式会社 ノーテンパー型ハードバターとして使用可能な油脂組成物
EP2840899B1 (de) 2012-04-27 2016-09-14 General Mills, Inc. Salzhaltige fettteilchenzusammensetzungen, teig und daraus hergestellte backwaren sowie entsprechende verfahren
EP2692238A1 (de) * 2012-08-03 2014-02-05 Bunge Növényolajipari Zártköruen Muködo Részvénytársasag Neue Fettmischzusammensetzung
BR112017019892B1 (pt) 2015-03-18 2022-03-22 Cargill, Incorporated Emulsão de água em óleo com baixo teor de gordura, produto alimentício e composição
CN111378534B (zh) * 2018-12-27 2022-11-25 丰益(上海)生物技术研发中心有限公司 结构酯组合物及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1107206A (en) 1964-12-28 1968-03-27 Nat Biscuit Co Hard butter and chocolate coating composition containing same
EP0089082B1 (de) 1982-03-12 1985-07-24 Unilever N.V. Margarinefettzusammensetzung und Verfahren zur Herstellung einer solchen Fettzusammensetzung
GB8432058D0 (en) * 1984-12-19 1985-01-30 Unilever Plc Edible fat
DE69103845T2 (de) * 1990-08-02 1995-02-02 Unilever Nv Verbesserung essbarer Fette.
DK0530864T3 (da) * 1991-07-03 1995-08-28 Unilever Plc Forbedrede chokoladesammensætninger
US5470598A (en) * 1994-03-23 1995-11-28 The Procter & Gamble Company Beta-prime stable low-saturate, low trans, all purpose shortening
US6238926B1 (en) * 1997-09-17 2001-05-29 Cargilll, Incorporated Partial interesterification of triacylglycerols
GB2350618A (en) 1999-06-01 2000-12-06 Danisco Shortening systems comprising a non-hydrogenated vegetable oil and either a stearine fraction or a saturated fatty acid diglyceride

Also Published As

Publication number Publication date
BR0308747A (pt) 2005-01-11
RU2307517C2 (ru) 2007-10-10
AU2003218752A1 (en) 2003-10-20
WO2003084337A1 (en) 2003-10-16
US7524524B2 (en) 2009-04-28
AU2003218752B2 (en) 2006-12-07
ZA200407149B (en) 2006-02-22
CA2481700A1 (en) 2003-10-16
RU2004132825A (ru) 2005-06-10
ATE457649T1 (de) 2010-03-15
PL371725A1 (en) 2005-06-27
EP1492410B1 (de) 2010-02-17
MXPA04009732A (es) 2005-01-11
PL205287B1 (pl) 2010-03-31
EP1492410A1 (de) 2005-01-05
BR0308747B1 (pt) 2013-12-17
CA2481700C (en) 2012-10-09
US20050220965A1 (en) 2005-10-06

Similar Documents

Publication Publication Date Title
DE60331298D1 (de) Triglyceridfett
MY178510A (en) Plastic fat composition
DK1290119T3 (da) Fremstilling af en blanding af triglycerider
DK1682226T3 (da) Lipidpræparat til forbedring af mineralabsorption
ATE551908T1 (de) Triglyceridfett
BRPI0517098A (pt) composições de óleo de sementes
ATE538658T1 (de) Ölzusammensetzung aus konjugierter linolsäure
BRPI0416403A (pt) composição de óleo enriquecida em diglicerìdeo com ácido linoléico conjugado
CN100526445C (zh) 含有长链高度不饱和脂肪酸的抗氧脂肪或油组合物
RU2013142936A (ru) Шоколадный или шоколадоподобный материал и способ его получения
AR078195A1 (es) Composicion antitranspirante y desodorante
TW200617173A (en) Process for production of microbial fat/oil containing discretional amount of diacylglycerol and said fat/oil
HUP0402214A2 (hu) Önthető zsírdiszperziók
WO2007078311A3 (en) Non-hydrogenated vegetable oil based margarine
DK0455278T3 (da) Spiselige fedtstoffer
PL1907519T3 (pl) Zastosowanie fulerenu C60 jako stabilizatora olejów zawierających fosfoglicerydy
BRPI0519634A2 (pt) mÉtodo para aumentar o némero de cetano de uma composiÇço de combustÍvel diesel, e, uso de um faae em uma composiÇço de combustÍvel diesel
EP1965652A4 (de) Verkürzung auf basis nicht-hydrogenierten pflanzenöls mithilfe einer erhöhten diglycerin-emulgatoren-zusammensetzung
MY134678A (en) A process for obtaining an oil composition and the oil composition obtained therefrom
BR0202991A (pt) Composição de ésteres de esterol-ácido graxo e alimentos contendo a mesma
ATE138531T1 (de) Triglyceride-zusammensetzungen gegen fettbleichen
WO2004108871A3 (fr) Compositions liquides a base d'huile de colza oleique modifiee, utiles a titre de liquides isolants et caloporteurs, et dispositifs electriques les contenant
PL1706002T3 (pl) Smakowa kompozycja żywnościowa zawierająca kompozycję tłuszczową ubogą w transtriglicerydy
BR9913554A (pt) Composição de gordura plástica com caloria reduzida
UA105482C2 (uk) Соняшник з низьким вмістом насичених жирів

Legal Events

Date Code Title Description
8364 No opposition during term of opposition